Interferon therapy: the other face of the medal.
Licata
Anna
A
Craxì
Antonio
A
D015415:Biomarkers; D003371:Cough / Q000209:etiology; D004359:Drug Therapy, Combination; D042241:Early Diagnosis; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008262:Macrophage Activation / Q000187:drug effects; D008297:Male; D018579:Patient Selection; D007703:Peptidyl-Dipeptidase A / Q000097:blood; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use; D017565:Sarcoidosis, Pulmonary / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology
D015415:Biomarkers; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin; D007703:Peptidyl-Dipeptidase A